Last reviewed · How we verify
NCT03736746
Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals
NA trial testing Motivational Interviewing in Other Cancer in 54 participants. Completed in 2 August 2019.
2 August 2019
Quick facts
| Lead sponsor | Dana-Farber Cancer Institute |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 54 |
| Start date | 16 November 2018 |
| Primary completion | 2 August 2019 |
| Estimated completion | 2 August 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Motivational Interviewing
Conditions studied
- Other Cancer — all drugs for Other Cancer →
Sponsor
Dana-Farber Cancer Institute
Who can join
18 and older, any sex, with Other Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research study is evaluating the acceptability and feasibility of using a cognitive behavioral intervention called Motivational Interviewing to help persons with pain from cancer set goals for managing that pain.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03736746
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Motivational Interviewing
Trials testing the same drug.
- NCT07218471 — Cannabis Reduction and Functional Outcomes · NA · recruiting
- NCT07415707 — The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in N · NA · recruiting
- NCT07364773 — Enhancing Rehabilitation Participation in Patients With SCI/D Using Motivational Interviewing · NA · recruiting
- NCT07169955 — The Effect of Motivational Interviewing on Patients With Lumbar Discectomy · NA · completed
- NCT06852664 — Improving Activity in Individuals With Cerebral Palsy · NA · recruiting
Other recruiting trials for Other Cancer
Currently open trials in the same condition.
- NCT06397651 — A Randomised Controlled Trial to Evaluate the Impact of Complement Theory's Live CoActive Exercise Coaching and Personal · NA · active not recruiting
- NCT06103669 — Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS) · NA · recruiting
- NCT04585750 — The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) · Phase 1, PHASE2 · recruiting
- NCT04340024 — Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients · recruiting
- NCT03752268 — Development of an Intervention to Enhance Cancer Pain Management · NA · active not recruiting
Other Dana-Farber Cancer Institute trials
Trials by the same sponsor.
- NCT07519200 — Sexual Health and Rehabilitation for Women With Metastatic Breast Cancer (SHARE-MC): An Educational Intervention · NA · not yet recruiting
- NCT07499999 — Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk fo · Phase 2 · not yet recruiting
- NCT05825469 — Development and Testing of Nutritional Algorithms (NACHO) · NA · not yet recruiting
- NCT07516353 — my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults · NA · not yet recruiting
- NCT07513324 — Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0) · Phase 2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03736746 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dana-Farber Cancer Institute
- Last refreshed: 25 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03736746.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing